Loading...
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
BACKGROUND: CD19 is a B cell lineage specific surface receptor whose broad expression, from pro-B cells to early plasma cells, makes it an attractive target for the immunotherapy of B cell malignancies. In this study we present the generation of a novel humanized anti-CD19 monoclonal antibody (mAb),...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4021825/ https://ncbi.nlm.nih.gov/pubmed/24731302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-7-33 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|